$27.36 -0.2 -0.6%
Last Trade - 19/04/21
| Market Cap | £920.5m |
| Enterprise Value | £1.10bn |
| Revenue | £352.3m |
| Position in Universe | 2614th / 6847 |
| Industry | Market | |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
| Year End 31st Dec | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021E | 2022E | CAGR / Avg | |
|---|---|---|---|---|---|---|---|---|---|---|
| 797.5 | 590.2 | 647.8 | 700.8 | 668.2 | 487.3 | 479.8 | 537 | -9.4% | ||
| -46.5 | -52.1 | +24.9 | -3.4 | +16.9 | +51.9 | |||||
|
x
|
||||||||||
| Profitability | ||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
| Cashflow | ||||||||||
| Dividends | ||||||||||
| Balance Sheet | ||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing % | |||
| Net Gearing % | |||
| Cash / Assets % |
| Liquidity (ttm) | ||
|---|---|---|
| Curr. Ratio | ||
| Quick Ratio | ||
| Interest Cov. | ||
| Efficiency (ttm) | ||
|---|---|---|
| Asset Turnover | ||
| Recs Turnover | ||
| Stock Turnover | ||
| Latest interim period vs. prior period | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
| 3yr Compound Annual Growth Rate | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
Revenue
Net Income
Normalised EPS
PE Ratio Range
Dividend Yield Range
|
Price Target:
( below Price)
|
31st Dec 2021
|
31st Dec 2022
|
||||
|---|---|---|---|---|---|---|
| Est. Long Term Growth Rate: |
Net Profit () |
EPS () |
DPS () |
Net Profit () |
EPS () |
DPS () |
| Consensus Estimate | ||||||
| 1m Change | ||||||
| 3m Change | ||||||
Core Laboratories N.V. provides reservoir description, production enhancement and reservoir management services to the oil and gas industry. The Company operates through three segments: Reservoir Description, Production Enhancement and Reservoir Management. The Reservoir Description segment encompasses the characterization of petroleum reservoir rock, fluid and gas samples. It provides analytical and field services to characterize properties of crude oil and petroleum products to the oil and gas industry. The Production Enhancement segment includes products and services relating to reservoir well completions, perforations, stimulations and production. It provides integrated diagnostic services to evaluate the effectiveness of well completions. The Reservoir Management segment combines and integrates information from reservoir description and production enhancement services to increase production and recovery of oil and gas from its clients' reservoirs.
| Last Annual | December 31st, 2020 |
| Last Interim | December 31st, 2020 |
| Incorporated | July 8, 1994 |
| Public Since | July 10, 1998 |
| No. of Shareholders: | 219 |
| No. of Employees: | 3,700 |
| Sector | Energy |
| Industry | Oil & Gas Related Equipment and Services |
| Index | S&P 600 Small Cap , S&P Composite 1500 , |
| Exchange | New York Stock Exchange |
| Shares in Issue | 46,240,478 |
| Free Float | (0.0%) |
| Eligible for |
✓
ISAs
✓
SIPPs
|
| Address | Tower a Level 9 Strawinskylaan 913, AMSTERDAM, 1077 XX, Netherlands |
| Web | https://www.corelab.com/ |
| Phone | +31 24 203191 |
| Contact | () |
| Auditors | KPMG LLP |
As of 19/04/21, shares in Core Laboratories NV are trading at $27.36, giving the company a market capitalisation of £920.5m. This share price information is delayed by 15 minutes.
Shares in Core Laboratories NV are currently trading at $27.36 and the price has moved by 0.155k% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Core Laboratories NV price has moved by 75.54% over the past year.
Of the analysts with advisory recommendations for Core Laboratories NV, there are there are currently 1 "buy" , 8 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Core Laboratories NV is Hold. You can view the full broker recommendation list by unlocking its StockReport.
Core Laboratories NV is scheduled to issue upcoming financial results on the following dates:
The Core Laboratories NV dividend yield is 1.02% based on the trailing twelve month period.
Last year, Core Laboratories NV paid a total dividend of 0.28, and it currently has a trailing dividend yield of 1.02%. Looking ahead, Core Laboratories NV has not announced an ex-dividend date yet.
Core Laboratories NV has yet to annouce their ex-dividend date. The historic dividend yield on Core Laboratories NV shares is currently 1.02%.
To buy shares in Core Laboratories NV you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
Shares in Core Laboratories NV are currently trading at $27.36, giving the company a market capitalisation of £920.5m.
Here are the trading details for Core Laboratories NV:
Based on an overall assessment of its quality, value and momentum, Core Laboratories NV is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Shares in Core Laboratories NV are currently priced at $27.36. At that level they are trading at 5.05% discount to the analyst consensus target price of 0.00.
Analysts covering Core Laboratories NV currently have a consensus Earnings Per Share (EPS) forecast of 0.84 for the next financial year.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Core Laboratories NV. Over the past six months, the relative strength of its shares against the market has been 52.34%. At the current price of $27.36, shares in Core Laboratories NV are trading at 9.22% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
We were not able to find PE ratio data for Core Laboratories NV.
Core Laboratories NV's management team is headed by:
Here are the top five shareholders of Core Laboratories NV based on the size of their shareholding:
